Company: LIMN
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001104659-25-010605
Chunk: 28

Company: Liminatus Pharma, Inc.
Filing Date: 2025-02-07
Form: 424B3
Chunk 28
---
 Thomas Jefferson University and Targeted Diagnostics & Therapeutics, Inc., as may have been amended.

“ Transactions ” means, collectively, the Mergers, Business Combination and the other transactions contemplated by the Business Combination Agreement.

“ Transfer Agent” means Continental Stock Transfer & Trust Company, a New York corporation.

“ Treasury regulations ” means the regulations promulgated by the U.S. Treasury Department under the Code.

“ Trust Account ” means the trust account into which the net proceeds of our IPO and the private placement were deposited for the benefit of the public stockholders and which held total assets of approximately $2,001,033 (as adjusted for redemptions paid out of the Trust Account in January 2025) as of January 2, 2025.

“ Trust Agreement ” means that certain Investment Management Trust Account Agreement, dated March 4, 2021, between Iris and Continental Stock Transfer & Trust Company.

“ Valetudo ” means Valetudo Therapeutics LLC.

“ Valetudo Assignment ” means that that certain Assignment of Contract entered into as of October 1, 2022, as amended, by and between Valetudo and the Company.

<div align='center'>vi</div>

TABLE OF CONTENTS

“ Viral Gene ” means Viral Gene, Inc.

“ Viral Gene Assignment ” means that certain Assignment of Contract by and between Viral Gene, and the Company, dated as of April 10, 2020.

“ Viral Gene License ” means the License and Development Agreement dated as of September 8, 2016, as amended, by and between Viral Gene and Targeted Diagnostics & Therapeutics, Inc., as may have been amended, granting exclusive worldwide rights to Develop and Commercialize the Vaccine Product in the Field and non‑exclusive worldwide rights to Develop and Commercialize the Companion Diagnostics to the Vaccine Products in the Field (such italicized terms bearing the meanings ascribed to them in the Viral Gene License).

“ Warrant Agreement ” means that certain Warrant Agreement, dated as of March 4, 2021, by and between Iris and Continental Stock Transfer & Trust Company, as warrant agent.

“ Warrant Amendment” means the Assumption of Warrant Agreement, to be entered into at Closing, by and among Iris, ParentCo and Continental Stock Transfer & Trust Company, as warrant agent, attached to this proxy statement/prospectus as Annex J .

<div align='center'>vii</div>

TABLE OF CONTENTS

### QUESTIONS